IMPACT-CABG Trial: Implantation of CD133+ Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient
Joint Authors
Forcillo, Jessica
Prieto, Ignacio
Noiseux, Nicolas
Stevens, Louis Mathieu
Mansour, Samer
Roy, Denis-Claude
Source
Case Reports in Transplantation
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-06-22
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The IMPACT-CABG study is the first Canadian randomized-controlled phase II clinical trial aiming to assess the effect of intramyocardial (IM) injections of CD133+-selected stem cells in patients referred for coronary artery bypass graft (CABG) with a “chronic” myocardial infarction and persistent left ventricular dysfunction.
Patients are followed for 2 years with different imaging techniques including the stress magnetic resonance to evaluate the global and regional myocardial viability.
Before the beginning of the randomization, the 5 first patients are treated in an open-label fashion to assess safety and feasibility of the IM CD133+ injections.
Herein, we report the first Canadian patient treated with IM injection of CD133+ cells during CABG surgery as part of the IMPACT-CABG trial.
American Psychological Association (APA)
Forcillo, Jessica& Stevens, Louis Mathieu& Mansour, Samer& Prieto, Ignacio& Roy, Denis-Claude& Noiseux, Nicolas. 2011. IMPACT-CABG Trial: Implantation of CD133+ Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient. Case Reports in Transplantation،Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-1027632
Modern Language Association (MLA)
Forcillo, Jessica…[et al.]. IMPACT-CABG Trial: Implantation of CD133+ Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient. Case Reports in Transplantation No. 2011 (2011), pp.1-3.
https://search.emarefa.net/detail/BIM-1027632
American Medical Association (AMA)
Forcillo, Jessica& Stevens, Louis Mathieu& Mansour, Samer& Prieto, Ignacio& Roy, Denis-Claude& Noiseux, Nicolas. IMPACT-CABG Trial: Implantation of CD133+ Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient. Case Reports in Transplantation. 2011. Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-1027632
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1027632
